ストックスクリーナーアプリを入手
114.47
3.58%
3.96
アフターアワーズ：
114.95
0.48
+0.42%
前日終値:
$110.51
開ける：
$110.61
24時間の取引高:
727.89K
Relative Volume:
0.64
時価総額：
$12.37B
収益：
$769.10M
当期純損益:
$46.67M
株価収益率:
327.06
EPS:
0.35
ネットキャッシュフロー:
$119.79M
1週間 パフォーマンス:
+3.34%
1か月 パフォーマンス:
+26.53%
6か月 パフォーマンス:
+186.39%
1年 パフォーマンス:
+58.99%
1日の値動き範囲:
$110.08
$114.90
1週間の範囲:
$110.05
$114.90
52週間の値動き範囲:
$28.66
$122.21
Corcept Therapeutics Inc Stock (CORT) Company Profile
名前
Corcept Therapeutics Inc
セクター
電話
650.688.8803
住所
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Compare CORT vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
114.47 | 12.13B | 769.10M | 46.67M | 119.79M | 0.35 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-05-13 | アップグレード | UBS | Neutral → Buy |
| 2026-03-26 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2025-12-31 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2025-12-16 | 開始されました | UBS | Neutral |
| 2025-11-18 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-06 | アップグレード | Truist | Hold → Buy |
| 2023-04-11 | 開始されました | SVB Securities | Market Perform |
| 2023-04-04 | 開始されました | Piper Sandler | Overweight |
| 2023-02-15 | ダウングレード | Jefferies | Buy → Hold |
| 2022-08-01 | ダウングレード | Truist | Buy → Hold |
| 2022-07-27 | アップグレード | Jefferies | Hold → Buy |
| 2022-06-27 | 再開されました | Canaccord Genuity | Buy |
| 2022-02-02 | 開始されました | Canaccord Genuity | Buy |
| 2022-01-28 | 開始されました | Truist | Buy |
| 2020-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2019-09-24 | 開始されました | Jefferies | Buy |
| 2019-09-06 | 開始されました | H.C. Wainwright | Buy |
| 2019-02-04 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | 繰り返されました | Stifel | Hold |
| 2018-05-31 | ダウングレード | Stifel | Buy → Hold |
| 2018-03-09 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | 開始されました | Stifel | Buy |
| 2017-02-02 | 開始されました | Ladenburg Thalmann | Buy |
| 2015-04-21 | 開始されました | FBR Capital | Outperform |
| 2014-01-13 | ダウングレード | Stifel | Buy → Hold |
| 2013-08-09 | ダウングレード | Janney | Buy → Neutral |
| 2013-08-09 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2010-01-06 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | 開始されました | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | アップグレード | Punk, Ziegel & Co | Mkt Perform → Accumulate |
すべてを表示
Corcept Therapeutics Inc (CORT) 最新ニュース
23,257 Shares in Corcept Therapeutics Incorporated $CORT Purchased by GSA Capital Partners LLP - marketbeat.com
Corcept therapeutics chief development officer sells $1.8m in stock - Investing.com
CORT Stock Slips After-Hours On Weak Q4 Print: Retail Is Watching April FDA Meeting For Relacorilant As Next Catalyst - Stocktwits
Corcept Therapeutics (CORT) CBO reports 17,530-share stock gifts and trust holdings - Stock Titan
Renaissance Technologies (CORT) discloses 4.90% beneficial stake in Corcept Therapeutics - Stock Titan
Corcept Therapeutics Incorporat (CORT) Stock Forecasts - Yahoo Finance
Sean Maduck Sells 1,031 Shares of Corcept Therapeutics (NASDAQ:CORT) Stock - marketbeat.com
William Guyer Sells 16,300 Shares of Corcept Therapeutics (NASDAQ:CORT) Stock - marketbeat.com
Corcept chief development officer sells $418,561 of stock By Investing.com - Investing.com Nigeria
Corcept chief development officer sells $418,561 of stock - Investing.com
Sei Investments Co. Sells 62,377 Shares of Corcept Therapeutics Incorporated $CORT - marketbeat.com
Amundi Acquires New Shares in Corcept Therapeutics Incorporated $CORT - marketbeat.com
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline (PR Newswire) - Aktiellt
California State Teachers Retirement System Boosts Stake in Corcept Therapeutics Incorporated $CORT - marketbeat.com
12,478 Shares in Corcept Therapeutics Incorporated $CORT Purchased by Evanson Financial LLC - marketbeat.com
Corcept Therapeutics Incorporat (CORT) Stock forecasts - Yahoo Finance UK
Corcept Therapeutics (CORT) Stock May Trade At A Discount Yet A Premium On Sales - Yahoo Finance
Corcept CDO William Guyer sells $418,561 in common stock By Investing.com - Investing.com South Africa
Corcept CDO William Guyer sells $418,561 in common stock - Investing.com
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells 3,700 Shares - MarketBeat
Janus Henderson Group PLC Acquires 10,817 Shares of Corcept Therapeutics Incorporated $CORT - marketbeat.com
Corcept Therapeutics (NASDAQ:CORT) Insider Sells 20,305 Shares of Stock - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Joseph Douglas Lyon Sells 1,540 Shares of Stock - MarketBeat
Corcept Therapeutics Stock Shines at New All-Time Highs Despite Its Valuation - Yahoo Finance
Corcept Therapeutics' (NASDAQ:CORT) Anemic Earnings Might Be Worse Than You Think - Moomoo
Parallel Advisors LLC Buys 96,763 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
CORT (NASDAQ: CORT) insider schedules 20,000-share option-related sale - Stock Titan
John Hussman's Top Q2 2026 Move: Exiting Corcept Therapeutics In - GuruFocus
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) CFO Sells $9,176,800.00 in Stock - MarketBeat
Corcept Therapeutics (CORT) CFO exercises options and sells 80,000 shares - Stock Titan
CORCEPT THERAPEUTICS INC SEC Filing (Aug 3, 2026) - Stock Titan
FAS Wealth Partners Inc. Grows Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Perceptive Advisors LLC Takes Position in Corcept Therapeutics Incorporated $CORT - marketbeat.com
Edgestream Partners L.P. Invests $2.79 Million in Corcept Therapeutics Incorporated $CORT - marketbeat.com
Corcept Therapeutics (NASDAQ:CORT) Upgraded at Wall Street Zen - marketbeat.com
Corcept: Commercial Evidence with Agentic Call Report - Veeva
Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know - webull.com
Piper Sandler Reaffirms Their Buy Rating on Corcept Therapeutics (CORT) - The Globe and Mail
27,200 Shares in Corcept Therapeutics Incorporated $CORT Purchased by OMERS ADMINISTRATION Corp - marketbeat.com
Form 144 | Corcept Therapeutics(CORT.US) Officer Proposes to Sell 4.59 Million in Common Stocks - Moomoo
Corcept Therapeutics Raises 2026 Revenue Outlook on Momentum - The Globe and Mail
Corcept Therapeutics (NASDAQ:CORT) Reaches New 52-Week High Following Earnings Beat - marketbeat.com
Corcept Therapeutics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Corcept: Q2 Earnings Snapshot - KVUE
Corcept Therapeutics (CORT) Stock Rises on Q2 2026 Earnings - Quiver Quantitative
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update - Business Wire
Bank of New York Mellon Corp Has $21.92 Million Stock Position in Corcept Therapeutics Incorporated $CORT - marketbeat.com
Spotting Winners: Corcept (NASDAQ:CORT) And Branded Pharmaceuticals Stocks In Q1 - Yahoo Finance
Corcept (CORT) Q2 Earnings: What To Expect - TradingView
CORT|Corcept Therapeutics Inc|Price:91.090|Chg%:-4.270 - TradingKey
Corcept Therapeutics Inc (CORT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Corcept Therapeutics Inc (CORT) 財務データ
収益
当期純利益
現金流量
EPS
0.52%
0.07%
大文字化:
|
ボリューム (24 時間):